Thomas Kander
Clinical trials sponsored by Thomas Kander, explained in plain language.
-
Lower platelet transfusion threshold safe for central line placement, study suggests
Knowledge-focused CompletedThis study looked at whether it is safe to lower the number of platelets needed before placing a central line (a special IV) in patients with blood disorders. Normally, patients get a platelet transfusion if their count is below 50, but this study tested a lower trigger of 10. Th…
Sponsor: Thomas Kander • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Massive study reveals hidden dangers of common hospital procedure
Knowledge-focused CompletedThis observational study followed over 29,000 patients who received a central venous catheter (a large IV placed in a major vein) to see how often immediate complications like bleeding, collapsed lung, or nerve injury occur. Researchers aim to identify factors that raise the risk…
Sponsor: Thomas Kander • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
New device aims to reduce needle sticks during central line placement
Knowledge-focused CompletedThis study tested whether using a needle guide during ultrasound-guided subclavian vein catheterization reduces the number of skin punctures. 300 adults in Sweden were randomly assigned to have the procedure with or without the guide. The goal is to see if the guide makes the pro…
Phase: NA • Sponsor: Thomas Kander • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC